Announcements Trials

Browse Landscape

Phase

Status

Completed 13 Unknown 10 Terminated 8 Recruiting 7 Active not recruiting 5 Withdrawn 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1

Interventions

Carboplatin 126 Cisplatin 125 Drug Therapy 104 Bevacizumab 98 Oxaliplatin 97 Capecitabine 96 Radiotherapy 94 Gemcitabine 87 Paclitaxel 85 tislelizumab 84 Cyclophosphamide 83 Specimen Handling 80 pembrolizumab 76 toripalimab 67 Magnetic Resonance Spectroscopy 63 Injections 62 Fluorouracil 62 sintilimab 57 anlotinib 53 Surgical Procedures, Operative 50 130-nm albumin-bound paclitaxel 50 Docetaxel 49 fludarabine 46 Pemetrexed 45 Standard of Care 43 venetoclax 42 Leucovorin 42 Biopsy 42 Irinotecan 41 lenvatinib 40

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Interventional × 1-dodecylpyridoxal × Clear all

NCT07564141 2026-06-03

RAINFOL™-07

Genmab

Phase 3 Not yet recruiting

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡